Autoimmune Disease Diagnostics: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Veröffentlicht von: precision business insights
Veröffentlicht am: 19.02.2018 10:46
Rubrik: Gesundheit & Medizin


(Presseportal openBroadcast) - Autoimmune Disease Diagnostics: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Pressekontakt:

Market Outline: Autoimmune Disease Diagnostics Market

The immune system protects the body from infections and diseases. In autoimmune disorders low or overactivity of immune system may appear. There is no exact cause of autoimmune diseases are identified. In response to unknown trigger, immune system produces antibodies that instead of fighting infections, attacks body own tissues. Autoimmune diseases diagnosed with blood tests and review of disease history, symptoms and physical examination. Rheumatoid arthritis, type-1 diabetes, multiple sclerosis and lupus some of the major autoimmune diseases.

Market Dynamics: Autoimmune Disease Diagnostics Market

Global autoimmune disease diagnostics market is driven by government initiatives towards increasing awareness in public about autoimmune disorders. In addition, increase in R&D investments and rising prevalence of autoimmune disorders are expected to boost the global autoimmune disease diagnostics market. However, high cost of diagnosis, limited awareness in developing and underdeveloped countries are expected to hinder the market growth. In addition, chances of false results coupled with lack of skilled professionals are expected to hamper the global autoimmune disease diagnostics market over the forecast period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/autoimmune-disease-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx


Market Scope: Autoimmune Disease Diagnostics Market
Global Autoimmune Disease Diagnostics market is segmented based on type, disease and end-user

Based on type, global autoimmune disease diagnostics are segmented into

• Systemic Autoimmune Disease
• Local Autoimmune Disease

Based on disease, it is segmented into

• Diabetes Type-1
• Rheumatoid Arthritis
• Multiple Sclerosis
• Others

Based on end user,it is segmented into

• Diagnostic Centers
• Hospitals
• Research Laboratories
• Others


To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/autoimmune-disease-diagnostics-market/#ulp-c654SbFYO64MsOhu


Market Summary: Autoimmune Disease Diagnostics Market

Global autoimmune disease diagnostics market is expected to grow at significant rate owing to growing rates of autoimmune diseases. According to National Multiple Sclerosis Society (MS), approximately, 2.3 Mn people are living with multiple sclerosis worldwide. The market is composed of multinational and local companies involved in offering autoimmune diagnostics. Major players are involving in R&D for development and introduction of new diagnostics into the market. Market players are collaborating in order to develop the new diagnostics for the autoimmune diseases and further increasing the market portfolio. For instance, in November 2014, Protagen AG entered into a long-term collaboration with Qiagen to develop an innovative companion diagnostic development platform for autoimmune disorders. Furthermore, government and non-profit organizations are taking initiatives to increase the awareness and involving in development of diagnostics for autoimmune diseases.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/autoimmune-disease-diagnostics-market/#ulp-14mlyhjMGhVjZqa3


Regional Analysis: Autoimmune Disease Diagnostics Market

Geographically, global autoimmune disease diagnostics market is segmented into following regions, viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to be major market for autoimmune disease diagnostics owing to increase in prevalence of autoimmune disorders, presence of many market players, and government initiatives to promote the autoimmune disease awareness. Europe is expected to expand at significant growth rate for global autoimmune disease diagnostics due to growing awareness and rising prevalence of autoimmune diseases. Asia-Pacific is expected to grow at faster rates owing to expansion of MNC’s into the developing countries of the region such as India.


Competition Assessment: Autoimmune Disease Diagnostics Market

Some of the players in global autoimmune disease diagnostics market are Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMerieux SA (France), Siemens AG (Siemens Healthineers) (Germany), Inova Diagnostics Inc. (Werfen Life Group, S.A.(Spain), Bio-Rad Laboratories (U.S.), MBL International Corporation (U.S.) and Quest Diagnostics Inc. (U.S.).

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/autoimmune-disease-diagnostics-market/




Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht openBroadcast verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss.